Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma Patients

기사 요약

Pfizer reports positive Phase 3 ELREXFIO data showing reduced disease progression risk in relapsed or refractory multiple myeloma patients.